United Arab Emirates Thyroid Eye Disease Market Size & Outlook, 2026-2034


United Arab Emirates Thyroid Eye Disease Market Insights

  • As per Reed Intelligence insights, the United Arab Emirates Thyroid Eye Disease Market stood at USD 45.29 Million in 2025 and is anticipated to grow to USD 79.34 Million by 2034.
  • The United Arab Emirates market is expected to advance at a CAGR of 6.44% from 2026 through 2034.
  • In 2025, Biologics accounted for the highest share of the Therapy Type market size.
  • During the forecast period, Small Molecule Drugs is set to register the highest growth, making it the most lucrative Therapy Type segment.

Other Key Findings


  • United Arab Emirates contributed 3.84% to the global Thyroid Eye Disease Market size in 2025.
  • By 2034, United States is forecasted to remain the largest global market for Thyroid Eye Disease Market.
  • In Middle East and Africa, United Arab Emirates is projected to capture the leading share of market size by 2034.
  • Among Middle East and Africa markets, Saudi Arabia is expected to post the fastest growth, reaching USD 37.94 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 45.29 Million
Market Size In 2034 USD 79.34 Million
Largest segment Biologics
Units Revenue in USD Million
CAGR 6.44% (2026-2034)
Segmnetation Covered
Therapy Type
  1. Biologics
  2. Small Molecule Drugs
  3. Corticosteroids
Treatment Approach
  1. Pharmacological Therapy
  2. Combination Therapy
  3. Surgical Intervention
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports